TY - JOUR
T1 - Visuospatial exploration and art therapy intervention in patients with Parkinson's disease
T2 - an exploratory therapeutic protocol
AU - Cucca, A.
AU - Acosta, I.
AU - Berberian, M.
AU - Lemen, A. C.
AU - Rizzo, J. R.
AU - Ghilardi, M. F.
AU - Quartarone, A.
AU - Feigin, A. S.
AU - Di Rocco, A.
AU - Biagioni, M. C.
N1 - Funding Information:
This study is supported by The Kellar Family Fundation, Grant ID # C17-00191. The Sponsor had no role in the study design, collection, analysis and interpretation of data, writing of the report and in the decision to submit the article for publication.
Funding Information:
This study is funded by The Kellar Family Foundation, P.O. Box 3547, Manassas, VA United States 20108-0964. The funding source had no role in the design, analysis or conclusions of the study.
Publisher Copyright:
© 2018
PY - 2018/10
Y1 - 2018/10
N2 - Though abnormalities of visuospatial function occur in Parkinson's disease, the impact of such deficits on functional independence and psychological wellbeing has been historically under- recognized, and effective treatments for this impairment are unknown. These symptoms can be encountered at any stage of the disease, affecting many activities of daily living, and negatively influencing mood, self-efficacy, independence, and overall quality of life. Furthermore, visuospatial dysfunction has been recently linked to gait impairment and falls, symptoms that are known to be poor prognostic factors. Here, we aim to present an original modality of neurorehabilitation designed to address visuospatial dysfunction and related symptoms in Parkinson's disease, known as “Art Therapy”. Art creation relies on sophisticated neurologic mechanisms including shape recognition, motion perception, sensory-motor integration, abstraction, and eye-hand coordination. Furthermore, art therapy may enable subjects with disability to understand their emotions and express them through artistic creation and creative thinking, thus promoting self-awareness, relaxation, confidence and self-efficacy. The potential impact of this intervention on visuospatial dysfunction will be assessed by means of combined clinical, behavioral, gait kinematic, neuroimaging and eye tracking analyses. Potential favorable outcomes may drive further trials validating this novel paradigm of neurorehabilitation.
AB - Though abnormalities of visuospatial function occur in Parkinson's disease, the impact of such deficits on functional independence and psychological wellbeing has been historically under- recognized, and effective treatments for this impairment are unknown. These symptoms can be encountered at any stage of the disease, affecting many activities of daily living, and negatively influencing mood, self-efficacy, independence, and overall quality of life. Furthermore, visuospatial dysfunction has been recently linked to gait impairment and falls, symptoms that are known to be poor prognostic factors. Here, we aim to present an original modality of neurorehabilitation designed to address visuospatial dysfunction and related symptoms in Parkinson's disease, known as “Art Therapy”. Art creation relies on sophisticated neurologic mechanisms including shape recognition, motion perception, sensory-motor integration, abstraction, and eye-hand coordination. Furthermore, art therapy may enable subjects with disability to understand their emotions and express them through artistic creation and creative thinking, thus promoting self-awareness, relaxation, confidence and self-efficacy. The potential impact of this intervention on visuospatial dysfunction will be assessed by means of combined clinical, behavioral, gait kinematic, neuroimaging and eye tracking analyses. Potential favorable outcomes may drive further trials validating this novel paradigm of neurorehabilitation.
KW - Art therapy
KW - Neurorehabilitation
KW - Parkinson's disease
KW - Visuospatial functions
UR - http://www.scopus.com/inward/record.url?scp=85051365690&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051365690&partnerID=8YFLogxK
U2 - 10.1016/j.ctim.2018.07.011
DO - 10.1016/j.ctim.2018.07.011
M3 - Article
C2 - 30219472
AN - SCOPUS:85051365690
SN - 0965-2299
VL - 40
SP - 70
EP - 76
JO - Complementary Therapies in Medicine
JF - Complementary Therapies in Medicine
ER -